A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver

This study has been terminated.

( recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated )

Study NCT00582400 Information provided by The University of Texas, Galveston

First Received: December 19, 2007 Last Updated: January 7, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	August 2012
Estimated Primary Completion Date:	August 2012 (Final data collection date for primary outcome measure)